Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nischalan Pillay

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.
Cancer Medicine|May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapyM Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Genome Biology|November 27, 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcomaWilliam Cross, Iben Lyskjær, Christopher Davies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2019
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangementFernanda Amary, Luis Perez-Casanova, Hongtao Ye, et al.
Cancer Letters|November 26, 2025
Profiling the genomic landscape and evolutionary history of polyploid giant cancer cells in undifferentiated pleomorphic sarcomasAmy L Bowes, Sara Waise, Tom Lesluyes, et al.
Endocrine-Related Cancer|July 19, 2021
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasmsAlexa Childs, Christopher D Steele, Clare Vesely, et al.
Cancer Research|August 29, 2020
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell DeathLucia Cottone, Adam P Cribbs, Garima Khandelwal, et al.
Cancer Discovery|June 29, 2024
The History of Chromosomal Instability in Genome-Doubled TumorsToby M Baker, Siqi Lai, Andrew R Lynch, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimicsNadège Presneau, Daniel Baumhoer, Sam Behjati, et al.
The American Journal of Surgical Pathology|December 21, 2018
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 CasesFlorian Puls, Nischalan Pillay, Henrik Fagman, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.
Cancer Medicine|May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapyM Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Genome Biology|November 27, 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcomaWilliam Cross, Iben Lyskjær, Christopher Davies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2019
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangementFernanda Amary, Luis Perez-Casanova, Hongtao Ye, et al.
Cancer Letters|November 26, 2025
Profiling the genomic landscape and evolutionary history of polyploid giant cancer cells in undifferentiated pleomorphic sarcomasAmy L Bowes, Sara Waise, Tom Lesluyes, et al.
Endocrine-Related Cancer|July 19, 2021
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasmsAlexa Childs, Christopher D Steele, Clare Vesely, et al.
Cancer Research|August 29, 2020
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell DeathLucia Cottone, Adam P Cribbs, Garima Khandelwal, et al.
Cancer Discovery|June 29, 2024
The History of Chromosomal Instability in Genome-Doubled TumorsToby M Baker, Siqi Lai, Andrew R Lynch, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimicsNadège Presneau, Daniel Baumhoer, Sam Behjati, et al.
The American Journal of Surgical Pathology|December 21, 2018
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 CasesFlorian Puls, Nischalan Pillay, Henrik Fagman, et al.
Pageof 7